These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27111168)

  • 1. Clinical outcomes of drug-eluting stents versus bare-metal stents in patients with cardiogenic shock complicating acute myocardial infarction.
    Chen DY; Mao CT; Tsai ML; Chen SW; Lin YS; Hsieh IC; Hung MJ; Wang CH; Wen MS; Cherng WJ; Chen TH
    Int J Cardiol; 2016 Jul; 215():98-104. PubMed ID: 27111168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes of Drug-Eluting Stents vs. Bare-Metal Stents in Acute Myocardial Infarction Patients Under Dialysis - A Nationwide Cohort Study.
    Chen DY; Mao CT; Tsai ML; Hsieh MJ; Lin YS; Cherng WJ; Wen MS; Wang CH; Hsieh IC; Hung MJ; Chen CC; Chen TH
    Circ J; 2016; 80(2):363-70. PubMed ID: 26581755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Ledwoch J; Fuernau G; Desch S; Eitel I; Jung C; de Waha S; Poess J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
    Heart; 2017 Aug; 103(15):1177-1184. PubMed ID: 28174212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.
    Mao CT; Chen TH; Tseng CN; Chen SW; Hsieh IC; Hung MJ; Chu PH; Wang CH; Wen MS; Cherng WJ; Chen DY
    PLoS One; 2019; 14(4):e0214417. PubMed ID: 30943217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis.
    Jaguszewski M; Ghadri JR; Seifert B; Hiestand T; Herrera P; Gaemperli O; Landmesser U; Maier W; Nallamothu BK; Windecker S; Lüscher TF; Templin C
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):220-9. PubMed ID: 24979116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year cardiovascular outcomes of drug-eluting stent versus bare-metal stent implanted in diabetic patients with acute coronary syndrome.
    Lai CC; Lin TH; Yip HK; Liu CP; Li AH; Shyu KG; Chang SC; Mar GY
    J Chin Med Assoc; 2016 May; 79(5):239-47. PubMed ID: 26943977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of one-year cardiac events with drug-eluting versus bare metal stent implantation in rescue coronary angioplasty.
    De Felice F; Fiorilli R; Parma A; Musto C; Nazzaro MS; Stefanini GG; Caferri G; Violini R
    Am J Cardiol; 2011 Jan; 107(2):210-4. PubMed ID: 21129713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
    Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
    Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ
    JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
    Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR
    Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation.
    Auer J; Leitner A; Berent R; Lamm G; Lassnig E; Krennmair G
    Atherosclerosis; 2010 Jun; 210(2):503-9. PubMed ID: 20060973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study.
    Chang NC; Hu P; Chen TH; Mao CT; Hung MJ; Yeh CT; Hung MY
    PLoS One; 2020; 15(1):e0227571. PubMed ID: 31923246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trial.
    Räber L; Kelbæk H; Taniwaki M; Ostojic M; Heg D; Baumbach A; von Birgelen C; Roffi M; Tüller D; Engstrøm T; Moschovitis A; Pedrazzini G; Wenaweser P; Kornowski R; Weber K; Lüscher TF; Matter CM; Meier B; Jüni P; Windecker S;
    Circ Cardiovasc Interv; 2014 Jun; 7(3):355-64. PubMed ID: 24847017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.